[HTML][HTML] Antimalarial market composition and performance in Nigeria and the Democratic Republic of Congo: results from 2013 ACTwatch outlet surveys

M Littrell, R Sudoi, J Archer, J Ngigi… - Malaria …, 2014 - malariajournal.biomedcentral.com
Background Nigeria and the Democratic Republic of Congo (DRC) together account for one-
third of the estimated global total of malaria cases and 40% of malaria deaths. Improving …

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries

KA O'Connell, H Gatakaa, S Poyer, J Njogu, I Evance… - Malaria journal, 2011 - Springer
Background Artemisinin-based combination therapy (ACT) is the first-line malaria treatment
throughout most of the malaria-endemic world. Data on ACT availability, price and market …

The ACTwatch project: methods to describe anti-malarial markets in seven countries

T Shewchuk, KA O'Connell, C Goodman, K Hanson… - Malaria Journal, 2011 - Springer
Background Policy makers, governments and donors are faced with an information gap
when considering ways to improve access to artemisinin-based combination therapy (ACT) …

Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda

M Woldeghebriel, E Aso, E Berlin, C Fashanu… - Malaria Journal, 2024 - Springer
Background An estimated 50% of suspected malaria cases in sub-Saharan Africa first seek
care in the private sector, especially in private medicine retail outlets. Quality of care in these …

What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African …

S Tougher, K Hanson, C Goodman - Malaria journal, 2017 - Springer
Background The private sector supplies anti-malarial treatment for large proportions of
patients in sub-Saharan Africa. Following the large-scale piloting of the Affordable …

[HTML][HTML] Effect of the Affordable Medicines Facility for malaria (AMFm) on the availability of antimalarials in Nigeria

A Joda, N Ezeigwe, L Oguguo, O Taylor… - MalariaWorld …, 2015 - ncbi.nlm.nih.gov
Background Malaria is one of the most important causes of mortality worldwide. Use of the
most effective treatments remains inadequate for those in need and there is concern over …

Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in …

AL Malisa, D Kiriba - BMC research notes, 2012 - Springer
Background Universal access to effective treatments is a goal of the Roll Back Malaria
Partnership. However, despite official commitments and substantial increases in financing …

Trends in access to anti‐malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first‐line anti‐malarials and …

D Kibira, A Ssebagereka, HA van den Ham, J Opigo… - Malaria Journal, 2021 - Springer
Background Malaria is the single largest cause of illness in Uganda. Since the year 2008,
the Global Fund has rolled out several funding streams for malaria control in Uganda …

A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western …

U Kioko, C Riley, S Dellicour, V Were, P Ouma… - Malaria Journal, 2016 - Springer
Background Although anti-malarial medicines are free in Kenyan public health facilities,
patients often seek treatment from private sector retail drug outlets. In mid-2010, the …

Survey of antimalarial drugs prices and availability in retail outlets in Enugu urban South East Nigeria

CC Ezenduka, J Okonta, BO Ogbonna - Value in Health, 2013 - valueinhealthjournal.com
Objectives The study investigated the local retail drug market to determine the prices,
availability and affordability of antimalarial medicines to generate information for improving …